Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | +1.10% | +0.73% | +10.40% |
06-03 | Oncocyte Corporation Announces Promising Results in A Phase 2 Clinical Trial | CI |
05-30 | Oncocyte Corporation Announces Favorable Oncocyte Vitgraft Kidney Study Results | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.40% | 36.89M | |
+11.68% | 3.7B | |
+0.37% | 2.28B | |
-21.21% | 1.99B | |
-23.77% | 1.6B | |
+14.81% | 999M | |
+18.25% | 739M | |
-10.04% | 685M | |
-36.12% | 461M | |
-4.47% | 279M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Oncocyte Cuts Workforce by 20%